Cargando…

The Molecular Role of IL-35 in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and a common cause of cancer-related death. Better understanding of the molecular mechanisms, pathogenesis, and treatment of NSCLC can help improve patient outcomes. Significant progress has been made in the treatment of NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Yuqiu, Dong, Hongna, Li, Wei, Lv, Xuejiao, Shi, Bingqing, Gao, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204334/ https://www.ncbi.nlm.nih.gov/pubmed/35719927 http://dx.doi.org/10.3389/fonc.2022.874823

Ejemplares similares

IL-36 Cytokines: Their Roles in Asthma and Potential as a Therapeutic
por: Dong, Hongna, et al.
Publicado: (2022)

Case Report: Patient With Lung Adenocarcinoma With ALK-HLA-DRB1 Rearrangement Shows Impressive Progression-Free Survival After Sequential Crizotinib and Ceritinib Treatment
por: Gao, Peng, et al.
Publicado: (2022)

Distribution of inflammatory phenotypes among patients with asthma in Jilin Province, China: a cross-sectional study
por: Shi, Bingqing, et al.
Publicado: (2021)

TIPE2 May Target the Nrf2/HO-1 Pathway to Inhibit M1 Macrophage–Related Neutrophilic Inflammation in Asthma
por: Shi, Bingqing, et al.
Publicado: (2022)

Significance of pleural effusion detected by metagenomic next-generation sequencing in the diagnosis of aspiration pneumonia
por: Zhu, Ling, et al.
Publicado: (2022)

Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study
por: Dong, Hongna, et al.
Publicado: (2020)

Characteristics of inflammatory phenotypes among patients with asthma: relationships of blood count parameters with sputum cellular phenotypes
por: Shi, Bingqing, et al.
Publicado: (2021)

The role of IL-35 and IL-37 in breast cancer – potential therapeutic targets for precision medicine
por: Ma, Yuntao, et al.
Publicado: (2022)

IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer
por: Kourko, Olena, et al.
Publicado: (2019)

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer
por: Baird, Anne-Marie, et al.
Publicado: (2013)

Role of Radiotherapy in Metastatic Non-Small Cell Lung Cancer
por: Faria, Sergio L.
Publicado: (2014)

The Role of Long Non-Coding RNAs in Thyroid Cancer
por: Peng, Xuejiao, et al.
Publicado: (2020)

Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway
por: Han, Linzhi, et al.
Publicado: (2022)

The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Xu, Yangyang, et al.
Publicado: (2021)

Prediction of the Mechanism of Sodium Butyrate against Radiation-Induced Lung Injury in Non-Small Cell Lung Cancer Based on Network Pharmacology and Molecular Dynamic Simulations
por: Zhang, Xiao-zhen, et al.
Publicado: (2022)

Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
por: Larousserie, Frédérique, et al.
Publicado: (2019)

Harmonization of Molecular Testing for Non-Small Cell Lung Cancer: Emphasis on PD-L1
por: Imyanitov, Evgeny N., et al.
Publicado: (2020)

Hippocampal Metastasis Rate Based on Non-Small Lung Cancer TNM Stage and Molecular Markers
por: Ahn, Sung Jun, et al.
Publicado: (2022)

Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer
por: Zhu, Jiaqi, et al.
Publicado: (2022)

Role of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer in the COVID-19 Pandemic
por: Karaman, Elanur, et al.
Publicado: (2022)

The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
por: Yan, Tinghao, et al.
Publicado: (2022)

Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
por: Zhao, Jiangang, et al.
Publicado: (2020)

Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth
por: Jiao, Peng-Fei, et al.
Publicado: (2021)

Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study
por: Wang, Suyu, et al.
Publicado: (2021)

Elevated levels of IL-17A and IL-35 in plasma and bronchoalveolar lavage fluid are associated with checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer
por: Wang, Yi Na, et al.
Publicado: (2020)

Role of Pneumonectomy in T1–4N2M0 Non-Small Cell Lung Cancer: A Propensity Score Matching Analysis
por: Wang, Suyu, et al.
Publicado: (2022)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

The Role of Transcriptional Factor Brachyury on Cell Cycle Regulation in Non-small Cell Lung Cancer
por: Xu, Jingyi, et al.
Publicado: (2020)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

Interluekin-35 in Asthma and Its Potential as an Effective Therapeutic Agent
por: Gao, Peng, et al.
Publicado: (2017)

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer
por: Shen, Qinglin, et al.
Publicado: (2023)

Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases
por: Liu, Hao, et al.
Publicado: (2022)

Drug Resistance to Molecular Targeted Therapy and Its Consequences for Treatment Decisions in Non-Small-Cell Lung Cancer
por: Spaans, Johanna N., et al.
Publicado: (2014)

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity
por: van den Broek, Daan, et al.
Publicado: (2020)

Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
por: Shi, Xiaoshun, et al.
Publicado: (2021)

Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
por: Peng, Yurong, et al.
Publicado: (2023)

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer
por: Hao, Bo, et al.
Publicado: (2020)

The Machine Learning Model for Distinguishing Pathological Subtypes of Non-Small Cell Lung Cancer
por: Zhao, Hongyue, et al.
Publicado: (2022)

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Wong, Annick
Publicado: (2017)

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
por: Nicoś, Marcin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6ve10m4carv9iv781s905ht951